Sarepta Therapeutics, Inc. (SRPT) Most Active Options

The 25 most actively traded Sarepta Therapeutics, Inc. (SRPT) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Aug 24, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$18.15
52-week range
$14.96 – $24.48
ATM IV (30d)
75.3%
IV rank
33 / 100
Low
Expected move
±$3.58 (±19.7%)
Put/call OI
1.05
Max pain
$17.5
↓ 3.6% below close
Next earnings
Nov 3, 2026

Most Active SRPT Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
SRPT $18 call Aug 28, 2026 4d $0.63 111.3% 77 0.53 455 218 0.4× avg
SRPT $17.5 put Sep 4, 2026 11d $0.44 55.9% 3 -0.36 0 100 2.4× avg
SRPT $20 call Sep 18, 2026 25d $0.39 56.0% 3 0.27 897 91 4.7× avg
SRPT $18.5 call Aug 28, 2026 4d $0.35 89.9% 53 0.41 25 70 0.1× avg
SRPT $16.5 put Aug 28, 2026 4d $0.05 78.1% 17 -0.13 0 64 3.5× avg
SRPT $25 call Nov 20, 2026 88d $0.65 68.5% 14 0.22 368 57 3.6× avg
SRPT $19 call Aug 28, 2026 4d $0.17 72.0% 12 0.25 29 52 1.8× avg
SRPT $25 call Jan 15, 2027 144d $1.47 69.2% 15 0.31 2,279 41 2.3× avg
SRPT $20 call Aug 28, 2026 4d $0.15 96.2% 28 0.16 92 37 1.3× avg
SRPT $22.5 call Sep 18, 2026 25d $0.10 57.9% 1 0.08 230 37 2.4× avg
SRPT $16 put Aug 28, 2026 4d $0.05 115.5% 55 -0.15 96 30 1.7× avg
SRPT $18.5 call Sep 18, 2026 25d $0.88 75.3% 33 0.49 28 2.4× avg
SRPT $40 call Jan 15, 2027 144d $0.20 76.7% 9 0.08 760 24 5.6× avg
SRPT $11.5 call Aug 28, 2026 4d $6.81 310.0% 62 0.94 0 23 6.5× avg
SRPT $18 put Aug 28, 2026 4d $0.60 68.3% 10 -0.48 19 23 2.4× avg
SRPT $30 call Nov 20, 2026 88d $0.25 68.0% 0 0.09 653 22 9.7× avg
SRPT $12.5 call Aug 28, 2026 4d $5.94 262.9% 53 0.93 0 20 5.7× avg
SRPT $21 call Sep 4, 2026 11d $0.10 88.0% 23 0.18 79 19 0.6× avg
SRPT $18.5 call Sep 4, 2026 11d $0.62 62.0% 25 0.43 22 19 0.2× avg
SRPT $17.5 put Nov 20, 2026 88d $1.90 65.9% 18 -0.39 230 18 1.3× avg
SRPT $22.5 call Nov 20, 2026 88d $1.18 66.3% 12 0.31 473 17 1.1× avg
SRPT $19 call Sep 4, 2026 11d $0.40 68.1% 11 0.35 33 16 0.5× avg
SRPT $17.5 put Aug 28, 2026 4d $0.21 51.5% 0 -0.28 139 16 2.2× avg
SRPT $17.5 put Oct 16, 2026 53d $1.20 61.0% 9 -0.40 24 14 1.0× avg
SRPT $20 call Jan 15, 2027 144d $2.70 74.3% 34 0.52 2,275 14 0.6× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active SRPT contract today is the $18 call expiring in 4 days, with 218 contracts traded. Calls dominate the most-active list (18 of the top 25), showing where trading interest concentrates.

Explore the payoff profile of option on SRPT for free

Build multi-leg SRPT strategies, visualize payoffs, and scan the full US options universe with OptiView.

SRPT Options FAQ

Which SRPT option contract is most active today?

The most traded SRPT contract is the $18 call expiring Aug 28, 2026, with 218 contracts traded as of Aug 24, 2026.

How does OptiView rank the most active SRPT options?

The table lists the 25 SRPT contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.